粘液型円形細胞脂肪肉腫治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2548)
◆英語タイトル:Global Myxoid Round Cell Liposarcoma Drug Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2548
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、粘液型円形細胞脂肪肉腫治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(トラベクテジン、メクロレタミン、その他)、用途別市場規模(病院、在宅医療、専門クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・粘液型円形細胞脂肪肉腫治療薬の市場動向
・企業の競争状況、市場シェア
・粘液型円形細胞脂肪肉腫治療薬の種類別市場規模(トラベクテジン、メクロレタミン、その他)
・粘液型円形細胞脂肪肉腫治療薬の用途別市場規模(病院、在宅医療、専門クリニック、その他)
・粘液型円形細胞脂肪肉腫治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・粘液型円形細胞脂肪肉腫治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・粘液型円形細胞脂肪肉腫治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・粘液型円形細胞脂肪肉腫治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・粘液型円形細胞脂肪肉腫治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Johnson & Johnson、Adaptimmune、GlaxoSmithKline plc、Merck & Co., Inc、Novartis、Infinity Pharmaceuticals, Inc、Mirati Therapeutics,Inc、Eli Lilly、Recordati SpA)
・結論
【レポートの概要】

Myxoid/round Cell Liposarcoma is also known as myxoliposarcoma is a malignant tumor that occurs in the body’s fat tissue most preferable found in the limbs. It is characterized by unusual pattern of metastasis to extrapulmonary sites. It has been found to be in geriatric male population.

Market Analysis and Insights: Global Myxoid Round Cell Liposarcoma Drug Market
The global Myxoid Round Cell Liposarcoma Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Myxoid Round Cell Liposarcoma Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Myxoid Round Cell Liposarcoma Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Myxoid Round Cell Liposarcoma Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Myxoid Round Cell Liposarcoma Drug market.

Global Myxoid Round Cell Liposarcoma Drug Scope and Market Size
Myxoid Round Cell Liposarcoma Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myxoid Round Cell Liposarcoma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Drug
Trabectedin
Mechlorethamine
Others
By Therapy
Chemotherapy
Radiation Therapy
Others
By Routes of Administration
Injectable
Oral

Segment by Application
Hospitals
Homecare
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Adaptimmune
GlaxoSmithKline plc
Merck & Co., Inc
Novartis
Infinity Pharmaceuticals, Inc
Mirati Therapeutics,Inc
Eli Lilly
Recordati SpA

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myxoid Round Cell Liposarcoma Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trabectedin
1.2.3 Mechlorethamine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myxoid Round Cell Liposarcoma Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Myxoid Round Cell Liposarcoma Drug Market Perspective (2016-2027)
2.2 Myxoid Round Cell Liposarcoma Drug Growth Trends by Regions
2.2.1 Myxoid Round Cell Liposarcoma Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myxoid Round Cell Liposarcoma Drug Historic Market Share by Regions (2016-2021)
2.2.3 Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Regions (2022-2027)
2.3 Myxoid Round Cell Liposarcoma Drug Industry Dynamic
2.3.1 Myxoid Round Cell Liposarcoma Drug Market Trends
2.3.2 Myxoid Round Cell Liposarcoma Drug Market Drivers
2.3.3 Myxoid Round Cell Liposarcoma Drug Market Challenges
2.3.4 Myxoid Round Cell Liposarcoma Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Myxoid Round Cell Liposarcoma Drug Players by Revenue
3.1.1 Global Top Myxoid Round Cell Liposarcoma Drug Players by Revenue (2016-2021)
3.1.2 Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Players (2016-2021)
3.2 Global Myxoid Round Cell Liposarcoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myxoid Round Cell Liposarcoma Drug Revenue
3.4 Global Myxoid Round Cell Liposarcoma Drug Market Concentration Ratio
3.4.1 Global Myxoid Round Cell Liposarcoma Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myxoid Round Cell Liposarcoma Drug Revenue in 2020
3.5 Myxoid Round Cell Liposarcoma Drug Key Players Head office and Area Served
3.6 Key Players Myxoid Round Cell Liposarcoma Drug Product Solution and Service
3.7 Date of Enter into Myxoid Round Cell Liposarcoma Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Myxoid Round Cell Liposarcoma Drug Breakdown Data by Type
4.1 Global Myxoid Round Cell Liposarcoma Drug Historic Market Size by Type (2016-2021)
4.2 Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Type (2022-2027)

5 Myxoid Round Cell Liposarcoma Drug Breakdown Data by Application
5.1 Global Myxoid Round Cell Liposarcoma Drug Historic Market Size by Application (2016-2021)
5.2 Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
6.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type
6.2.1 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
6.2.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
6.2.3 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
6.3 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application
6.3.1 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
6.3.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
6.3.3 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
6.4 North America Myxoid Round Cell Liposarcoma Drug Market Size by Country
6.4.1 North America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
6.4.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
7.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type
7.2.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
7.2.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
7.2.3 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
7.3 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application
7.3.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
7.3.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
7.3.3 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
7.4 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country
7.4.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
7.4.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
8.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type
8.2.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application
8.3.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region
8.4.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
9.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type
9.2.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
9.2.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
9.2.3 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
9.3 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application
9.3.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
9.3.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
9.3.3 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
9.4 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country
9.4.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
9.4.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
10.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type
10.2.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application
10.3.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country
10.4.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Introduction
11.1.4 Johnson & Johnson Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Adaptimmune
11.2.1 Adaptimmune Company Details
11.2.2 Adaptimmune Business Overview
11.2.3 Adaptimmune Myxoid Round Cell Liposarcoma Drug Introduction
11.2.4 Adaptimmune Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.2.5 Adaptimmune Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Introduction
11.3.4 GlaxoSmithKline plc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Company Details
11.4.2 Merck & Co., Inc Business Overview
11.4.3 Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Introduction
11.4.4 Merck & Co., Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.4.5 Merck & Co., Inc Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Myxoid Round Cell Liposarcoma Drug Introduction
11.5.4 Novartis Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Infinity Pharmaceuticals, Inc
11.6.1 Infinity Pharmaceuticals, Inc Company Details
11.6.2 Infinity Pharmaceuticals, Inc Business Overview
11.6.3 Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Introduction
11.6.4 Infinity Pharmaceuticals, Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.6.5 Infinity Pharmaceuticals, Inc Recent Development
11.7 Mirati Therapeutics,Inc
11.7.1 Mirati Therapeutics,Inc Company Details
11.7.2 Mirati Therapeutics,Inc Business Overview
11.7.3 Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Introduction
11.7.4 Mirati Therapeutics,Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.7.5 Mirati Therapeutics,Inc Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Myxoid Round Cell Liposarcoma Drug Introduction
11.8.4 Eli Lilly Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Recordati SpA
11.9.1 Recordati SpA Company Details
11.9.2 Recordati SpA Business Overview
11.9.3 Recordati SpA Myxoid Round Cell Liposarcoma Drug Introduction
11.9.4 Recordati SpA Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.9.5 Recordati SpA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 粘液型円形細胞脂肪肉腫治療薬の世界市場規模・現状・予測2021年-2027年(Global Myxoid Round Cell Liposarcoma Drug Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。